scholarly journals Differential Surface Expression and Phosphorylation of theN-Methyl-D-aspartate Receptor Subunits NR1 and NR2 in Cultured Hippocampal Neurons

1997 ◽  
Vol 272 (7) ◽  
pp. 4135-4140 ◽  
Author(s):  
Randy A. Hall ◽  
Thomas R. Soderling
2021 ◽  
Author(s):  
Zilin Li ◽  
Chenyu Gou ◽  
Wenhui Wang ◽  
Yuan Li ◽  
Yu Cui ◽  
...  

Abstract α7 neuronal nicotinic acetylcholine receptors (α7nAChRs) are expressed widely in the brain, where they contribute to a variety of behaviors including arousal and cognition, participate in a number of neurodegenerative disorders including Alzheimer’s and Parkinson’s disease, and is responsible for nicotine addiction. Although recent studies indicate that the PDZ-containing proteins comprising PSD-95 family co-localize with nicotinic acetylcholine receptors and mediate downstream signaling in the neurons, the mechanisms by which α7nAChRs are regulated are still less well understood. Here we show that the regulation of the α7nAChRs is controlled by PDLIM5 in the endogenous PDZ domain proteins family. We find that chronic exposure to 1 μM nicotine up-regulated both α7, β2-contained nAChRs and PDLIM5 in primary cultured hippocampal neurons, and the up-regulation of α7nAChRs and PDLIM5 is increased more on the cell membrane than the cytoplasm. Interestingly, the α7nAChRs and β2nAChRs display distinct patterns of expression, with α7 co-localized more with PDLIM5. Meanwhile, PDLIM5 interacts with native brain α7 but not β2 nAChRs in neurons. Moreover, knocking down of PDLIM5 in heterologous cells abolishes nicotine-induced up-regulation of α7nAChRs. In cultured hippocampal neurons, shRNA against PDLIM5 decreased both surface clustering of α7nAChRs and α7nAChRs mediated currents. Proteomics analysis shows PDLIM5 interacts with α7nAChRs through the PDZ domain and the interaction between PDLIM5 and α7nAChRs can be promoted by nicotine. Collectively, our data suggest a novel cellular role of PDLIM5 in regulating α7nAChRs, which may be relevant to plastic changes in the nervous system.


2021 ◽  
Vol 35 (8) ◽  
Author(s):  
Miranda Mele ◽  
Pasqualino De Luca ◽  
Ana Rita Santos ◽  
Marta Vieira ◽  
Ivan L. Salazar ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Kristyna Skrenkova ◽  
Jae-man Song ◽  
Stepan Kortus ◽  
Marharyta Kolcheva ◽  
Jakub Netolicky ◽  
...  

Abstract Although numerous pathogenic mutations have been identified in various subunits of N-methyl-D-aspartate receptors (NMDARs), ionotropic glutamate receptors that are central to glutamatergic neurotransmission, the functional effects of these mutations are often unknown. Here, we combined in silico modelling with microscopy, biochemistry, and electrophysiology in cultured HEK293 cells and hippocampal neurons to examine how the pathogenic missense mutation S688Y in the GluN1 NMDAR subunit affects receptor function and trafficking. We found that the S688Y mutation significantly increases the EC50 of both glycine and d-serine in GluN1/GluN2A and GluN1/GluN2B receptors, and significantly slows desensitisation of GluN1/GluN3A receptors. Moreover, the S688Y mutation reduces the surface expression of GluN3A-containing NMDARs in cultured hippocampal neurons, but does not affect the trafficking of GluN2-containing receptors. Finally, we found that the S688Y mutation reduces Ca2+ influx through NMDARs and reduces NMDA-induced excitotoxicity in cultured hippocampal neurons. These findings provide key insights into the molecular mechanisms that underlie the regulation of NMDAR subtypes containing pathogenic mutations.


PLoS ONE ◽  
2012 ◽  
Vol 7 (9) ◽  
pp. e46012 ◽  
Author(s):  
Jia Zhu ◽  
Chong-Yu Shao ◽  
Wei Yang ◽  
Xiao-Min Zhang ◽  
Zhen-Yong Wu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document